Skip to main content

Hemp Industry Faces Regulatory Storm After New Federal Funding Bill — But the Fight Isn’t Over



Hemp Industry Faces Regulatory Storm After New Federal Funding Bill — But the Fight Isn’t Over

The hemp industry is in a firefight right now — regrouping and preparing for a major lobbying push after a federal government funding package dropped a bombshell provision that could outlaw nearly all hemp-derived products containing THC.

What Just Happened?

The recently passed funding bill tightened the legal definition of hemp to ban any hemp-derived product with THC, even the types legalized by the landmark 2018 Farm Bill. The new rules cap THC at a microscopic 0.4 milligrams per container — a limit so tight that most hemp products, even the non-intoxicating ones, reportedly exceed it.

This crackdown also targets cannabinoids like delta-8 THC, which are synthesized or manufactured outside the plant. These now fall under the ban, too.

The Food and Drug Administration (FDA) has been given 90 days to release a list defining natural vs. synthetic cannabinoids and what exactly counts as a "container" for enforcement.

The Cost: Massive Losses Looming Across the Industry

This isn’t just a small regulatory tweak — it’s a hammer blow to a booming, still-nascent industry that’s been a lifeline for farmers, entrepreneurs, and consumers alike.

  • Farmers face lost income and sunk costs: The 2018 Farm Bill opened doors for hemp farmers looking to diversify crops and boost earnings. A harsh THC limit and broad bans threaten to wipe out revenue streams and leave farmers stuck with unsellable harvests.

  • Small and mid-sized producers risk closure: Hemp-derived products like tinctures, gummies, and beverages have exploded in popularity. Shutting down or severely limiting these products risks shuttering countless small businesses that fueled the industry’s rapid growth.

  • Retailers and marketplaces face inventory and compliance chaos: Hemp products are now mainstream — stocked in gas stations, convenience stores, and major retailers. The 0.4 mg rule could force massive product recalls, financial losses, and legal uncertainty.

  • Consumers lose choice and safe access: Millions have turned to hemp products for wellness, recreation, or as cannabis alternatives. This ban threatens to eliminate familiar options overnight.

  • Innovation stalls: Startups investing in research, product development, and scaling up face crushing uncertainty — innovation that benefits the economy and consumers could grind to a halt.

The U.S. Hemp Roundtable estimates the vast majority of hemp products on the market already exceed the 0.4 mg per container threshold, even those without intoxicating effects. Simply put, if this rule goes into effect as written, most hemp products could become illegal overnight.

Industry Response: Disappointed But Not Defeated

The U.S. Hemp Roundtable, a leading trade group, says the industry took a serious blow — but they’re ready for the challenge.

“We’re disappointed, but not defeated. Our new mission, friends: 365 days to regulate, NOT ban.”

This one-year grace period before the ban kicks in is their window to push for sensible regulation, not prohibition.

A promising draft bill from Rep. Morgan Griffith (R-Va.) could provide that framework. It proposes clear milligram thresholds, labeling rules, and a new chapter in the Food, Drug, and Cosmetic Act explicitly granting the FDA authority over hemp cannabinoid products.

Why Did This Happen?

The 2018 Farm Bill removed hemp from the controlled substances list to help farmers and expand hemp production — not just for smokable products, but also textiles, cosmetics, and more.

But the rapid growth of hemp-derived cannabinoid products — gummies, beverages, oils — caught lawmakers off guard. These products are now in gas stations, convenience stores, and even major retailers like Target, far beyond dispensaries.

The lack of FDA oversight created a wild west where intoxicating hemp products spread without standardization or safety controls.

Voices from the Front Lines

Michelle Bodian, head of regulatory affairs at the THC beverage brand Nowadays, stresses the need for scalable federal rules:

“Our goal is to help federal policymakers create a clear, enforceable framework that brings this fast-growing category into the mainstream while eliminating room for bad actors.”

Thomas Winstanley of Edibles.com echoes that urgency:

“This is not one year to a ban. This is one year to regulate. And the industry will do exactly that — united, determined, and unwilling to let Washington destroy what farmers built and consumers want.”

Opposition and Complications

On the other side, a mix of alcohol interests, cannabis companies, and marijuana prohibition groups pushed hard for these limits. Many fear intoxicating hemp products are being sold as legal loopholes for synthetic or unregulated cannabis products, often without age restrictions.

The American Trade Association for Cannabis and Hemp (ATACH) supports distinguishing intoxicating from non-intoxicating products:

“The intoxicating hemp marketplace is rife with bad actors peddling synthetic drugs and cannabis under the guise of hemp,” said Chris Lindsey, ATACH VP of policy.

Meanwhile, industry leaders like Anthony Coniglio from NewLake Capital call this a step forward but warn that true progress depends on comprehensive federal cannabis reform.

What’s Next?

The hemp industry is at a crossroads. The battle lines have been drawn between a booming market hungry for clear rules — and regulators and interest groups demanding tight controls.

The next 365 days will determine whether hemp-derived cannabinoids get a fair shot at regulation, or if Washington’s heavy hand will slam the door shut on this emerging market.

One thing’s for sure: hemp farmers, producers, and consumers aren’t going quietly into the night. The grassroots lobbying blitz is underway — and the story of hemp’s federal fate is far from finished.

Your Takeaway?

If you’re in hemp or just curious about the wild world of cannabinoids, watch this space closely. The FDA’s upcoming rulings and congressional moves could reshape what’s on store shelves in every gas station and grocery store near you.

The fight for hemp’s soul isn’t over — it’s only just heating up.


#LegalizeIt


Related Post 👉 Free the Green: A Letter to President Donald J. Trump


🏠 Home

Labels:

Comments

Post a Comment

People's Choice

A Thank You Letter To President Trump for Opening the Door to Cannabis Research

  Trump's Cannabis From Schedule I to Schedule III Move Dear President Trump, I want to extend a sincere and enthusiastic thank you for your leadership in considering and moving forward with the rescheduling of marijuana from a Schedule I to a Schedule III controlled substance — a step that has already begun to reshape the national conversation around cannabis, research, and medical science. Your public remarks acknowledging that many people want this reclassification because it “leads to tremendous amounts of research that can’t be done unless you reclassify” reflect a willingness to look beyond old stigmas and recognize the potential for science and medicine to understand cannabis more fully. This shift — which would acknowledge cannabis as a substance with accepted medical use and a lower potential for abuse relative to Schedule I drugs — marks one of the most significant federal policy considerations in decades. By opening the door to research, innovation, an...
Post a Comment
Read more

Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean

  Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean Schedule I vs Schedule III Under the U.S. Controlled Substances Act (CSA), drugs are classified into schedules based on their accepted medical use, potential for abuse, and risk of dependence. Two key schedules in this context are Schedule I and Schedule III: Schedule I : Drugs with no currently accepted medical use in the U.S., a high potential for abuse , and potentially severe psychological or physical dependence. Examples include heroin, LSD, and currently, marijuana (cannabis). Schedule III : Drugs with accepted medical use , moderate to low potential for physical and psychological dependence, and a lower abuse risk compared to Schedules I or II. Examples include ketamine, anabolic steroids, testosterone, and certain codeine combinations (like Tylenol with codeine). Rescheduling marijuana from Schedule I to Schedule III would formally recognize its medical benefits...
Post a Comment
Read more

What is Delta 9?

Delta-9 refers to delta-9-tetrahydrocannabinol , commonly known as THC . [Updated Nov. 15, 2025] Delta-9 Molecule  What Is Delta-9? Delta-9 THC is a naturally occurring chemical compound found in the cannabis plant. It belongs to a family of plant chemicals called cannabinoids, which are produced in the plant’s resin glands (the trichomes). At the molecular level, Delta-9 is an organic molecule made of carbon, hydrogen, and oxygen with the formula C₂₁H₃₀O₂. What defines it — and gives it its name — is the placement of a double bond on the ninth carbon atom in its molecular chain. That structural feature is what separates it from similar cannabinoids like Delta-8 or Delta-10. In the cannabis plant, Delta-9 forms through the breakdown of THC-A (tetrahydrocannabinolic acid) when it’s exposed to heat, drying, or aging. This process is called decarboxylation. Delta-9 is considered the primary and most abundant form of THC found in traditional marijuana strains and is a major c...
Post a Comment
Read more

Why Tennessee Should Legalize Marihuana

  Tennessee should legalize the marihuana version of cannabis for many reasons including the benefits of creating a nascent industry, providing medical benefits, and considering the historical lesson of alcohol prohibition .  Legalize It Tennessee Creating a nascent marihuana industry in Tennessee has the potential to bring a variety of economic benefits. A regulated marihuana market could yield increases in jobs, investment, tax revenue, and business innovation. Revenue from marihuana taxes can be allocated to public programs and services. Furthermore, legal marihuana can reduce costs associated with prosecuting and enforcing drug laws. Marihuana also has significant medicinal properties that could benefit the lives of Tennesseans. Research has shown that marihuana has therapeutic value in treating many medical conditions, including cancer, multiple sclerosis , PTSD , opioid addiction , and anxiety . By legalizing marihuana, Tennessee can offer citizens much-needed reli...
Post a Comment
Read more

Free the Green: A Letter to President Donald J. Trump

  🇺🇸 Free the Green: A Letter to President Donald J. Trump An Open Plea from the American People & the Cannabis Family Legalize It President Trump, It’s time to Free the Green — to remove marijuana from the federal Schedule I classification, where it has been trapped since the Nixon era. A Law Without a Vote Few Americans realize that marijuana’s placement as a Schedule I drug — supposedly with “no medical value and a high potential for abuse” — was never voted on by Congress . It was assigned there in 1970 under the Controlled Substances Act by executive direction, intended as a temporary classification until a scientific commission could study the plant and make recommendations. That commission, known as the Shafer Commission , did complete its work — and in 1972, it recommended that marijuana should not be criminalized and should be removed from Schedule I entirely. The findings were ignored. Politics won. Science lost. And for over fifty years, that mi...
Post a Comment
Read more